Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in older patients undergoing spinal surgery
ChiCTR-IPR-17013065Phase 4Not yet recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in Back disorder (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoints: Efficacy and Safety. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Back disorder
Beyond the preview
Go deeper on ChiCTR-IPR-17013065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013065.